Caplacizumab [915810-67-2]

MedChem Express

Caplacizumab [915810-67-2]

10

915810-67-2

Research Use Only

99.0

Caplacizumab (ALX-0681) is a humanized anti-von Willebrand factor (vWF) nanobody. Caplacizumab inhibits the binding of vWF with platelet glycoprotein (GP) Ibalpha. Caplacizumab inhibits the vWF-mediated platelet adhesion and prevents further microthrombi formation. Caplacizumab can be used for the research of thrombotic thrombocytopenic purpura (TTP)[1][2][3][4].

-80°C

41116161